YP
Yogeshkumar Prajapati
About Yogeshkumar Prajapati
Data last updated:
Yogeshkumar Prajapati has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Welcure Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Welcure Drugs And Pharmaceuticals Limited at ₹9.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Welcure Drugs And Pharmaceuticals Limited L68100DL1996PLC227773 | Director | 05 Aug 2025 | 1996 | ₹9.4 Lakh (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogeshkumar Prajapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogeshkumar Prajapati
Yogeshkumar Prajapati has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Welcure Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Welcure Drugs And Pharmaceuticals Limited at ₹9.4 Lakh (FY 2024).
Yogeshkumar Prajapati is associated with 1 company as Director, including Welcure Drugs And Pharmaceuticals Limited (₹9.4 Lakh).
Yogeshkumar Prajapati has expertise in General Business.
Yogeshkumar Prajapati has 1 years in corporate governance.
By reported revenue, the largest current company of Yogeshkumar Prajapati is Welcure Drugs And Pharmaceuticals Limited, with revenue of ₹9.4 Lakh (FY 2024).
Yogeshkumar Prajapati currently holds positions at 1 company: Welcure Drugs And Pharmaceuticals Limited (₹9.4 Lakh).